Old Web
English
Sign In
Acemap
>
Paper
>
aged 50 to 70: results of a randomized controlled trial Intermediate-dose melphalan improves survival of myeloma patients
aged 50 to 70: results of a randomized controlled trial Intermediate-dose melphalan improves survival of myeloma patients
2013
E Pogliani
Anna Marina Liberati
Franco Dammacco
Giovannino Ciccone
Mario
Federica Cavallo
Patrizia Falco
Cecilia Rus
Massimo Massaia
Franco Mandelli
Tommasina Guglielmelli
Mariella Grasso
Vincenzo Callea
Alessandra Bertola
Vito Michele Lauta
Cesare Bergonzi
Anna Maria Barbui
Tommaso Caravita
Antonio Capaldi
Antonio Palumbo
Sara Bringhen
Maria Teresa Petrucci
Pellegrino Musto
Fausto Rossini
Keywords:
Randomized controlled trial
Physical therapy
Melphalan
Medicine
Internal medicine
Oncology
Correction
Cite
Save
Machine Reading By IdeaReader
21
References
0
Citations
NaN
KQI
[]